The
National Cancer Institute, NIH, DHHS, is paving the way for new programs and discoveries
at NCI-Frederick. The HIV Drug Resistance Program (DRP) is a world-class
center for retrovirology research in a highly collaborative environment dedicated
purely to research and supported by a wide spectrum of state-of-the-art core facilities.
The emphasis of the DRP is on basic and translational research related to genetic
diversity and drug resistance. Currently,
the DRP is recruiting for the following positions:
Selection
of these positions will be based on merit, without discrimination for nonmerit
reasons such as race, color, religion, gender, national origin, politics, marital
status, physical or mental disability, age, sexual orientation, or membership
or nonmembership in an employee organization. These positions are subject
to a background investigation.
Note
for Foreign Scientists: Applicants should be aware that the recruitment
process is lengthy. Anyone currently holding a J1 visa and transferring
from an academic institution would be limited to three years from entrance into
the United States. For additional information, please visit the website
of the Fogarty
International Center. The
National Cancer Institute, NIH, DHHS, is an Equal Employment Opportunity and Affirmative
Action employer that values and fosters diversity throughout the entire organization.
Last
modified: 4 August 2008 |